INS and Hypoglycemia: While glucose-responsive insulin delivery systems arein widespreadclinical use to treat insulin insufficiency, the on-demand supplementationof glucagon for acute hypoglycemia treatment remains understudied.A self-regulated glucagon release material is highly desired to mitigatethe potential risks of severe insulin-induced hypoglycemia.